Cargando…

Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients

OBJECTIVE: Epigenetic modifications contribute to the etiology of type 2 diabetes. METHOD: We performed genome-wide methylome and transcriptome analysis in liver from severely obese men with or without type 2 diabetes and non-obese men to discover aberrant pathways underlying the development of insu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirchner, Henriette, Sinha, Indranil, Gao, Hui, Ruby, Maxwell A., Schönke, Milena, Lindvall, Jessica M., Barrès, Romain, Krook, Anna, Näslund, Erik, Dahlman-Wright, Karin, Zierath, Juleen R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770265/
https://www.ncbi.nlm.nih.gov/pubmed/26977391
http://dx.doi.org/10.1016/j.molmet.2015.12.004
_version_ 1782418231048273920
author Kirchner, Henriette
Sinha, Indranil
Gao, Hui
Ruby, Maxwell A.
Schönke, Milena
Lindvall, Jessica M.
Barrès, Romain
Krook, Anna
Näslund, Erik
Dahlman-Wright, Karin
Zierath, Juleen R.
author_facet Kirchner, Henriette
Sinha, Indranil
Gao, Hui
Ruby, Maxwell A.
Schönke, Milena
Lindvall, Jessica M.
Barrès, Romain
Krook, Anna
Näslund, Erik
Dahlman-Wright, Karin
Zierath, Juleen R.
author_sort Kirchner, Henriette
collection PubMed
description OBJECTIVE: Epigenetic modifications contribute to the etiology of type 2 diabetes. METHOD: We performed genome-wide methylome and transcriptome analysis in liver from severely obese men with or without type 2 diabetes and non-obese men to discover aberrant pathways underlying the development of insulin resistance. Results were validated by pyrosequencing. RESULT: We identified hypomethylation of genes involved in hepatic glycolysis and insulin resistance, concomitant with increased mRNA expression and protein levels. Pyrosequencing revealed the CpG-site within ATF-motifs was hypomethylated in four of these genes in liver of severely obese non-diabetic and type 2 diabetic patients, suggesting epigenetic regulation of transcription by altered ATF-DNA binding. CONCLUSION: Severely obese non-diabetic and type 2 diabetic patients have distinct alterations in the hepatic methylome and transcriptome, with hypomethylation of several genes controlling glucose metabolism within the ATF-motif regulatory site. Obesity appears to shift the epigenetic program of the liver towards increased glycolysis and lipogenesis, which may exacerbate the development of insulin resistance.
format Online
Article
Text
id pubmed-4770265
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-47702652016-03-14 Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients Kirchner, Henriette Sinha, Indranil Gao, Hui Ruby, Maxwell A. Schönke, Milena Lindvall, Jessica M. Barrès, Romain Krook, Anna Näslund, Erik Dahlman-Wright, Karin Zierath, Juleen R. Mol Metab Original Article OBJECTIVE: Epigenetic modifications contribute to the etiology of type 2 diabetes. METHOD: We performed genome-wide methylome and transcriptome analysis in liver from severely obese men with or without type 2 diabetes and non-obese men to discover aberrant pathways underlying the development of insulin resistance. Results were validated by pyrosequencing. RESULT: We identified hypomethylation of genes involved in hepatic glycolysis and insulin resistance, concomitant with increased mRNA expression and protein levels. Pyrosequencing revealed the CpG-site within ATF-motifs was hypomethylated in four of these genes in liver of severely obese non-diabetic and type 2 diabetic patients, suggesting epigenetic regulation of transcription by altered ATF-DNA binding. CONCLUSION: Severely obese non-diabetic and type 2 diabetic patients have distinct alterations in the hepatic methylome and transcriptome, with hypomethylation of several genes controlling glucose metabolism within the ATF-motif regulatory site. Obesity appears to shift the epigenetic program of the liver towards increased glycolysis and lipogenesis, which may exacerbate the development of insulin resistance. Elsevier 2016-01-02 /pmc/articles/PMC4770265/ /pubmed/26977391 http://dx.doi.org/10.1016/j.molmet.2015.12.004 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Kirchner, Henriette
Sinha, Indranil
Gao, Hui
Ruby, Maxwell A.
Schönke, Milena
Lindvall, Jessica M.
Barrès, Romain
Krook, Anna
Näslund, Erik
Dahlman-Wright, Karin
Zierath, Juleen R.
Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients
title Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients
title_full Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients
title_fullStr Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients
title_full_unstemmed Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients
title_short Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients
title_sort altered dna methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770265/
https://www.ncbi.nlm.nih.gov/pubmed/26977391
http://dx.doi.org/10.1016/j.molmet.2015.12.004
work_keys_str_mv AT kirchnerhenriette altereddnamethylationofglycolyticandlipogenicgenesinliverfromobeseandtype2diabeticpatients
AT sinhaindranil altereddnamethylationofglycolyticandlipogenicgenesinliverfromobeseandtype2diabeticpatients
AT gaohui altereddnamethylationofglycolyticandlipogenicgenesinliverfromobeseandtype2diabeticpatients
AT rubymaxwella altereddnamethylationofglycolyticandlipogenicgenesinliverfromobeseandtype2diabeticpatients
AT schonkemilena altereddnamethylationofglycolyticandlipogenicgenesinliverfromobeseandtype2diabeticpatients
AT lindvalljessicam altereddnamethylationofglycolyticandlipogenicgenesinliverfromobeseandtype2diabeticpatients
AT barresromain altereddnamethylationofglycolyticandlipogenicgenesinliverfromobeseandtype2diabeticpatients
AT krookanna altereddnamethylationofglycolyticandlipogenicgenesinliverfromobeseandtype2diabeticpatients
AT naslunderik altereddnamethylationofglycolyticandlipogenicgenesinliverfromobeseandtype2diabeticpatients
AT dahlmanwrightkarin altereddnamethylationofglycolyticandlipogenicgenesinliverfromobeseandtype2diabeticpatients
AT zierathjuleenr altereddnamethylationofglycolyticandlipogenicgenesinliverfromobeseandtype2diabeticpatients